80_FR_82083 80 FR 81832 - National Institute on Drug Abuse; Notice of Closed Meeting

80 FR 81832 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 251 (December 31, 2015)

Page Range81832-81832
FR Document2015-32939

Federal Register, Volume 80 Issue 251 (Thursday, December 31, 2015)
[Federal Register Volume 80, Number 251 (Thursday, December 31, 2015)]
[Notices]
[Page 81832]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-32939]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Board of Scientific Counselors, NIDA.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute on Drug Abuse, including consideration of personnel 
qualifications and performance, and the competence of individual 
investigators, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDA.
    Date: February 1-2, 2016.
    Closed: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Intramural Research Program, National Institute on Drug 
Abuse, NIH, Johns Hopkins Bayview Campus, Baltimore, MD 21223.
    Contact Person: Joshua Kysiak, Program Specialist, Biomedical 
Research Center, Intramural Research Program, National Institute on 
Drug Abuse, NIH, DHHS, 251 Bayview Boulevard, Baltimore, MD 21224, 
443-740-2465, kysiakjo@nida.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: December 28, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32939 Filed 12-30-15; 8:45 am]
BILLING CODE 4140-01-P



                                              81832                           Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices

                                                TABLE A.12–1.3—ESTIMATE OF RESPONDENT BURDEN, GENERATION 3 COHORT, NOS AND OMNI GROUP 2 COHORT—
                                                                                            Continued
                                                                                                                                         [Annualized]

                                                                                                                                                                                                       Average time
                                                                                                                                                                             Number of
                                                                                                                                                           Number of                                   per response              Total annual
                                                                                     Type of respondent                                                                    responses per
                                                                                                                                                          respondents                                   (hours per               burden hour
                                                                                                                                                                             respondent                    year)

                                                  2. Home or nursing home visit .................................................................                     35                         1                   60/60                 35
                                              C. POST-EXAM:
                                                  eFHS Mobile Technology for Collection of CVD Risks ............................                                  1,100                       18                     9/60              2,970
                                              D. ANNUAL FOLLOW-UP:
                                                  1. Records Request ..................................................................................            1,200                         1                   15/60                300
                                                  2. Health Status Update ...........................................................................              1,400                         1                   15/60                350

                                                          Sub-Total: Participant Components ..................................................                   * 2,850   ........................   ........................          6,830

                                                                                                    II. NON-PARTICIPANT COMPONENTS—ANNUAL FOLLOW-UP

                                              A. INFORMANT CONTACTS ..........................................................................                       180                         1                  10/60                  30
                                              B. RECORD REQUEST ..................................................................................                 1,155                         1                  15/60                 289

                                                    Sub-Total: Non-Participant Components ..................................................                       1,335   ........................   ........................            319

                                                          Total: Participant And Non-Participant Components ........................                               4,185   ........................   ........................          7,157
                                                 * Number of participants as reflected in Rows I.A.1 and I.D.2 above.


                                                Dated: December 22, 2015.                                          Place: Intramural Research Program,                         individuals associated with the grant
                                              Valery Gheen,                                                      National Institute on Drug Abuse, NIH, Johns                  applications, the disclosure of which
                                              NHLBI Project Clearance Liaison, National                          Hopkins Bayview Campus, Baltimore, MD                         would constitute a clearly unwarranted
                                              Institutes of Health.                                              21223.                                                        invasion of personal privacy.
                                                                                                                   Contact Person: Joshua Kysiak, Program
                                              [FR Doc. 2015–32940 Filed 12–30–15; 8:45 am]                       Specialist, Biomedical Research Center,                         Name of Committee: National Institute on
                                              BILLING CODE 4140–01–P                                             Intramural Research Program, National                         Drug Abuse Special Emphasis Panel; Tools
                                                                                                                 Institute on Drug Abuse, NIH, DHHS, 251                       for Monitoring and Manipulating RNA
                                                                                                                 Bayview Boulevard, Baltimore, MD 21224,                       Modifications (R41, R42, R43, R44).
                                              DEPARTMENT OF HEALTH AND                                           443–740–2465, kysiakjo@nida.nih.gov.                            Date: February 18, 2016.
                                              HUMAN SERVICES                                                     (Catalogue of Federal Domestic Assistance                       Time: 9:00 a.m. to 4:00 p.m.
                                                                                                                 Program Nos.: 93.279, Drug Abuse and                            Agenda: To review and evaluate grant
                                              National Institutes of Health                                      Addiction Research Programs, National                         applications.
                                                                                                                 Institutes of Health, HHS)                                      Place: Hilton Garden Inn Bethesda, 7301
                                              National Institute on Drug Abuse;                                                                                                Waverly Street, Bethesda, MD 20814.
                                                                                                                   Dated: December 28, 2015.                                     Contact Person: Jagadeesh S. Rao, Ph.D.,
                                              Notice of Closed Meeting
                                                                                                                 Natasha M. Copeland,                                          Scientific Review Officer, Office of
                                                                                                                 Program Analyst, Office of Federal Advisory                   Extramural Policy and Review, National
                                                Pursuant to section 10(d) of the                                                                                               Institute on Drug Abuse, National Institutes
                                              Federal Advisory Committee Act, as                                 Committee Policy.
                                                                                                                                                                               of Health, DHHS, 6001 Executive Boulevard,
                                              amended (5 U.S.C. App.), notice is                                 [FR Doc. 2015–32939 Filed 12–30–15; 8:45 am]
                                                                                                                                                                               Room 4234, MSC 9550, Bethesda, MD 02892,
                                              hereby given of a meeting of the Board                             BILLING CODE 4140–01–P                                        301–443–9511, jrao@nida.nih.gov.
                                              of Scientific Counselors, NIDA.                                                                                                  (Catalogue of Federal Domestic Assistance
                                                The meeting will be closed to the                                                                                              Program Nos.: 93.279, Drug Abuse and
                                                                                                                 DEPARTMENT OF HEALTH AND                                      Addiction Research Programs, National
                                              public as indicated below in accordance
                                                                                                                 HUMAN SERVICES                                                Institutes of Health, HHS)
                                              with the provisions set forth in section
                                              552b(c)(6), Title 5 U.S.C., as amended                             National Institutes of Health                                   Dated: December 28, 2015.
                                              for the review, discussion, and                                                                                                  Natasha M. Copeland,
                                              evaluation of individual intramural                                National Institute on Drug Abuse;                             Program Analyst, Office of Federal Advisory
                                              programs and projects conducted by the                             Notice of Closed Meeting                                      Committee Policy.
                                              National Institute on Drug Abuse,                                                                                                [FR Doc. 2015–32937 Filed 12–30–15; 8:45 am]
                                              including consideration of personnel                                 Pursuant to section 10(d) of the
                                                                                                                                                                               BILLING CODE 4140–01–P
                                              qualifications and performance, and the                            Federal Advisory Committee Act, as
                                              competence of individual investigators,                            amended (5 U.S.C. App), notice is
                                              the disclosure of which would                                      hereby given of the following meeting.
                                                                                                                                                                               DEPARTMENT OF HEALTH AND
                                              constitute a clearly unwarranted                                     The meeting will be closed to the
                                                                                                                                                                               HUMAN SERVICES
                                              invasion of personal privacy.                                      public in accordance with the
tkelley on DSK3SPTVN1PROD with NOTICES




                                                                                                                 provisions set forth in sections                              National Institutes of Health
                                                Name of Committee: Board of Scientific                           552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                              Counselors, NIDA.
                                                Date: February 1–2, 2016.
                                                                                                                 as amended. The grant applications and                        National Institute of Allergy and
                                                Closed: 8:30 a.m. to 5:00 p.m.                                   the discussions could disclose                                Infectious Diseases; Closed Meeting
                                                Agenda: To review and evaluate personal                          confidential trade secrets or commercial
                                              qualifications and performance, and                                property such as patentable materials,                          Pursuant to section 10(d) of the
                                              competence of individual investigators.                            and personal information concerning                           Federal Advisory Committee Act, as


                                         VerDate Sep<11>2014       16:49 Dec 30, 2015      Jkt 238001     PO 00000      Frm 00028      Fmt 4703     Sfmt 4703   E:\FR\FM\31DEN1.SGM        31DEN1



Document Created: 2015-12-31 02:14:50
Document Modified: 2015-12-31 02:14:50
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesFebruary 1-2, 2016.
FR Citation80 FR 81832 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR